Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Stem-cell scientists discover new view of how human blood is made

Stem-cell scientists discover new view of how human blood is made

Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

New clinical trial uses aggressive treatment method for patients with pancreas cancer

New clinical trial uses aggressive treatment method for patients with pancreas cancer

UCSD researchers suggest that cancer-related mutations common in patients with low blood counts

UCSD researchers suggest that cancer-related mutations common in patients with low blood counts

TUM researchers uncover signaling pathways that play vital role in self-renewal of blood stem cells

TUM researchers uncover signaling pathways that play vital role in self-renewal of blood stem cells

Blood stem cell self-renewal dependent on surroundings

Blood stem cell self-renewal dependent on surroundings

Key protein controls stem cell properties that could make them useful in regenerative medicine

Key protein controls stem cell properties that could make them useful in regenerative medicine

Resistance to CD19 CAR T-cell therapy can be caused by CD19 splicing alterations

Resistance to CD19 CAR T-cell therapy can be caused by CD19 splicing alterations

Researchers discover key regulator that impacts survival of lymphoma patients

Researchers discover key regulator that impacts survival of lymphoma patients

Specialized type of immunotherapy can boost survival from pancreatic cancer

Specialized type of immunotherapy can boost survival from pancreatic cancer

UNM CCC biostatisticians help scientists conduct research on cancer

UNM CCC biostatisticians help scientists conduct research on cancer

New research shows that autophagy can operate in cell nucleus to guard against start of cancer

New research shows that autophagy can operate in cell nucleus to guard against start of cancer

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Study suggests potential new way to block cancer-causing gene

Study suggests potential new way to block cancer-causing gene

ISIBELa joint research project aims to improve cancer therapy

ISIBELa joint research project aims to improve cancer therapy

Targeting invasive cells could be a new strategy to treat metastatic cancer, say Stony Brook researchers

Targeting invasive cells could be a new strategy to treat metastatic cancer, say Stony Brook researchers

New approaches to treating lung cancer patients in New Mexico

New approaches to treating lung cancer patients in New Mexico

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.